These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15878464)

  • 21. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three year controlled study in children with pollinosis treated with immunotherapy.
    Cantani A; Businco E; Benincori N; de Angelis M; di Fazio A; Businco L
    Ann Allergy; 1984 Jul; 53(1):79-84. PubMed ID: 6377983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy, can we improve it?
    Waldbott GL
    Ann Allergy; 1980 Jul; 45(1):56-8. PubMed ID: 7406243
    [No Abstract]   [Full Text] [Related]  

  • 24. Allergic rhinitis: evidence for impact on asthma.
    Thomas M
    BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S4. PubMed ID: 17140422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C; Monzón S; Venturini M; Lezaun A
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyposensitization in allergic rhinitis. Immunotherapy. Indications and contra-indications.
    Wihl JA
    Acta Otolaryngol Suppl; 1979; 360():19-21. PubMed ID: 287338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
    Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R; Stender A; Rak S
    Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
    Powell RJ; Frew AJ; Corrigan CJ; Durham SR
    Allergy; 2007 Nov; 62(11):1335-8. PubMed ID: 17714551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW; Passalacqua G
    Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific immunotherapy in pollen allergy.
    Wallner M; Briza P; Thalhamer J; Ferreira F
    Curr Opin Mol Ther; 2007 Apr; 9(2):160-7. PubMed ID: 17458170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A; Henzgen M; Rajakulasingam K
    Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The connection between allergic rhinitis and bronchial asthma.
    Corren J
    Curr Opin Pulm Med; 2007 Jan; 13(1):13-8. PubMed ID: 17133119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
    Brimnes J; Kildsgaard J; Jacobi H; Lund K
    Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR; Riis B
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.